{"id":2697,"date":"2021-10-19T16:04:43","date_gmt":"2021-10-19T14:04:43","guid":{"rendered":"https:\/\/www.socesfar.es\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/"},"modified":"2021-10-19T16:04:44","modified_gmt":"2021-10-19T14:04:44","slug":"actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019","status":"publish","type":"revista","link":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/","title":{"rendered":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019"},"content":{"rendered":"\n<p>Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?<br\/><a href=\"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/09\/AFTV17N3WEB.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019<\/a><\/p>\n\n<h4 class=\"wp-block-heading\"><strong>\u00cdndice<\/strong><\/h4>\n\n<ul class=\"wp-block-list\"><li><strong>Editorial de la Presidenta. <\/strong>\u00a1\u00a1\u00a1\u00a1Gracias!!!<\/li><li><strong>Editorial del Director.<\/strong>La cena de la Gaviota<\/li><li><strong>Editorial invitado.<\/strong>Las nuevas Gu\u00edas americanas (AHA\/ACC\/HRS) sobre el tratamiento de los pacientes con fibrilaci\u00f3n auricular<\/li><li><strong>Farmacoterapia<\/strong><ul><li>Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?<\/li><li>Suspendiendo la aspirina tras la intervenci\u00f3n coronaria percut\u00e1nea<\/li><li>Sevoflurano como analg\u00e9sicl\/anest\u00e9sido t\u00f3pico en heridas cr\u00f3nicas dolorosas: un nuevo ejemplo de reposicionamiento armacol\u00f3gico<\/li><\/ul><\/li><li><strong>Farmacogen\u00e9tica<\/strong><ul><li>Ajuste de dosis de azatioprina y 6-mercaptopurina de acuerdo con el genotipo de TPMT y NUDT15<\/li><\/ul><\/li><li><strong>Casos Farmacoter\u00e1picos<\/strong><ul><li>Uso de valproico en mujer en edad f\u00e9rtil<\/li><\/ul><\/li><li><strong>Fronteras en terap\u00e9utica<\/strong><ul><li>\u00c1cido Bempedoico como alternativa terap\u00e9utica combatiendo la hipecolesterolemia<\/li><li>Esketamina, un nuevo f\u00e1rmaco para la depresi\u00f3n grave<\/li><\/ul><\/li><li><strong>Farmacovigilancia<\/strong><ul><li>Noas de la AEMPS<\/li><\/ul><\/li><li><strong>Errores de medicaci\u00f3n<\/strong><ul><li>Metotrexato: nuevas meidas para evitar reacciones adversas por errores en su administraci\u00f3n<\/li><li>Visado de inspecci\u00f3n para medicamentos urgentes<\/li><li>Agentes antitrob\u00f3ticos<\/li><li>Lynparza (Olaparib): riesgo de errores de medicaic\u00f3n con la nueva forma famac\u00e9utica<\/li><\/ul><\/li><li><strong>El f\u00e1rmaco y la palabra<\/strong><ul><li>Simisi\u00f3n del abstract<\/li><li>Escribir ciencia en superlativo<\/li><li>Agonismos y agon\u00edas<\/li><\/ul><\/li><li><strong>La SEF informa<\/strong><ul><li>J\u00f3venes investigadores<\/li><\/ul><\/li><li><strong>Normas para los autores<\/strong><\/li><\/ul>","protected":false},"featured_media":0,"template":"","categoria_revista":[64],"class_list":["post-2697","revista","type-revista","status-publish","hentry","categoria_revista-2019-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019 - Sociedad Espa\u00f1ola de Farmacolog\u00eda<\/title>\n<meta name=\"description\" content=\"Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"og:description\" content=\"Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/\" \/>\n<meta property=\"og:site_name\" content=\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\" \/>\n<meta property=\"article:modified_time\" content=\"2021-10-19T14:04:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Socesfar\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\\\/\",\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019 - Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\"},\"datePublished\":\"2021-10-19T14:04:43+00:00\",\"dateModified\":\"2021-10-19T14:04:44+00:00\",\"description\":\"Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revista\\\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revistas\",\"item\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/revistas\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#organization\",\"name\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"contentUrl\":\"https:\\\/\\\/www.socesfar.es\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/logo-socesfar-02.png\",\"width\":383,\"height\":63,\"caption\":\"Sociedad Espa\u00f1ola de Farmacolog\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.socesfar.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/Socesfar\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/socesfar\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/","og_locale":"en_US","og_type":"article","og_title":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","og_description":"Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?","og_url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/","og_site_name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","article_modified_time":"2021-10-19T14:04:44+00:00","twitter_card":"summary_large_image","twitter_site":"@Socesfar","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/","url":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/","name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019 - Sociedad Espa\u00f1ola de Farmacolog\u00eda","isPartOf":{"@id":"https:\/\/www.socesfar.es\/en\/#website"},"datePublished":"2021-10-19T14:04:43+00:00","dateModified":"2021-10-19T14:04:44+00:00","description":"Discontinuaci\u00f3n del tratamiento en leucemia mieloide cr\u00f3nica, \u00bfun nuevo objetivo para nuestros pacientes?","breadcrumb":{"@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.socesfar.es\/en\/revista\/actualidad-en-farmacologia-y-terapeutica-vol-17-no-3-2019\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.socesfar.es\/en\/"},{"@type":"ListItem","position":2,"name":"Revistas","item":"https:\/\/www.socesfar.es\/en\/revistas\/"},{"@type":"ListItem","position":3,"name":"Actualidad en Farmacolog\u00eda y Terap\u00e9utica. Vol. 17, n\u00ba 3, 2019"}]},{"@type":"WebSite","@id":"https:\/\/www.socesfar.es\/en\/#website","url":"https:\/\/www.socesfar.es\/en\/","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","description":"","publisher":{"@id":"https:\/\/www.socesfar.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.socesfar.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.socesfar.es\/en\/#organization","name":"Sociedad Espa\u00f1ola de Farmacolog\u00eda","url":"https:\/\/www.socesfar.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","contentUrl":"https:\/\/www.socesfar.es\/wp-content\/uploads\/2021\/07\/logo-socesfar-02.png","width":383,"height":63,"caption":"Sociedad Espa\u00f1ola de Farmacolog\u00eda"},"image":{"@id":"https:\/\/www.socesfar.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/Socesfar","https:\/\/www.linkedin.com\/company\/socesfar\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista"}],"about":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/types\/revista"}],"version-history":[{"count":1,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2697\/revisions"}],"predecessor-version":[{"id":2698,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/revista\/2697\/revisions\/2698"}],"wp:attachment":[{"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/media?parent=2697"}],"wp:term":[{"taxonomy":"categoria_revista","embeddable":true,"href":"https:\/\/www.socesfar.es\/en\/wp-json\/wp\/v2\/categoria_revista?post=2697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}